Learn More
PURPOSE To evaluate the prevalence of retinal pigment epithelium (RPE) tears associated with anti-VEGF therapy and its relation with retinal pigment epithelial detachment (PED). METHODS A total of 226 patients with exudative age-related macular degeneration treated with intravitreal anti-VEGF were included retrospectively in the study. The presence of RPE(More)
PURPOSE To report a patient with central retinal artery occlusion with double cilioretinal artery sparing. METHODS Retrospective case report. RESULTS A 45-year-old woman presented with sudden vision loss in her left eye for 10 days. Her best-corrected visual acuity was counting fingers at 2 meters in the left eye and 20/20 in the right eye. Funduscopy(More)
OBJECTIVES To evaluate and compare the anatomical and functional outcomes of patients with acute central serous chorioretinopathy (CSC) who did not receive any intervention or treatment with intravitreal bevacizumab or ranibizumab. METHODS A single-center retrospective comparative study. Seventy eyes of 70 patients were recruited for the study; 27(More)
Introduction. Gyrate atrophy is a rare genetical metabolic disorder affecting vision. Here, we report a 9-year-old boy with gyrate atrophy associated with bilateral macular edema at the time of diagnosis and the effect of long term metabolic control on macular edema. Case Presentation. A 9-year-old boy presented with a complaint of low visual acuity (best(More)
PURPOSE To evaluate the lens densitometry values in eyes with macular edema secondary to retinal vein occlusion that were treated with intravitreal dexamethasone implants and to compare these data with those of fellow healthy control eyes. SETTING Ulucanlar Eye Training and Research Hospital, Ankara, Turkey. DESIGN Prospective case series. METHODS(More)
Purpose. To report a young male with unilateral central retinal vein occlusion (CRVO) associated with cryoglobulinemia. Case Presentation. A 33-year-old male without any known systemic or ocular disorder was admitted to our clinic with a complaint of visual loss for three days in his left eye. Based on the clinical, laboratory, and ophthalmological(More)
PURPOSE To evaluate the pain associated with intravitreal aflibercept injections. METHODS The study included 119 patients who received intravitreal aflibercept injection at a single institution. Pain was evaluated by visual analog scale (VAS) immediately after the injection of 2 mg/0.05 mL aflibercept into the vitreous cavity using a 27-G needle.(More)
  • 1